Corrigendum to “Therapeutic effect of ursolic acid in experimental visceral leishmaniasis” [Int. J. Parasitol. Drugs Drug Resist. 7 (2017) 1–11]

Corrigendum to “Therapeutic effect of ursolic acid in experimental visceral leishmaniasis” [Int. J. Parasitol. Drugs Drug Resist. 7 (2017) 1–11]

Bibliographic Details
Main Authors:	Jessica A. Jesus, Thais N. Fragoso, Eduardo S. Yamamoto, Marcia D. Laurenti, Marcelo S. Silva, Aurea F. Ferreira, João Henrique G. Lago, Gabriela Santos-Gomes, Luiz Felipe D. Passero
Format:	Article
Language:	English
Published:	Elsevier 2017-08-01
Series:	International Journal for Parasitology: Drugs and Drug Resistance
Online Access:	http://www.sciencedirect.com/science/article/pii/S2211320717300386

Similar Items

Therapeutic effect of ursolic acid in experimental visceral leishmaniasis
by: Jéssica A. Jesus, et al.
Published: (2017-04-01)

Corrigendum to “Genetic diversity of next generation antimalarial targets: A baseline for drug resistance surveillance programmes” [Int. J. Parasitol. Drugs and Drug Resist. 7 (2017) 174–180]
by: Ana Rita Gomes, et al.
Published: (2017-12-01)

Ursolic Acid Potentializes Conventional Therapy in Experimental Leishmaniasis
by: Jéssica Adriana Jesus, et al.
Published: (2020-10-01)

Preclinical Assessment of Ursolic Acid Loaded into Nanostructured Lipid Carriers in Experimental Visceral Leishmaniasis
by: Jéssica Adriana Jesus, et al.
Published: (2021-06-01)

Corrigendum to ‘Duplex quantitative Reverse-Transcriptase PCR for simultaneous assessment of drug activity against Leishmania intracellular amastigotes and their host cells’ [Int. J. Parasitol. Drugs Drug Resist. 4 (2014) 14–19]
by: Erika van den Bogaart, et al.
Published: (2016-08-01)

Evaluating the Potential of Ursolic Acid as Bioproduct for Cutaneous and Visceral Leishmaniasis
by: Pablo Bilbao-Ramos, et al.
Published: (2020-03-01)

Antimicrobial Activity of Oleanolic and Ursolic Acids: An Update
by: Jéssica A. Jesus, et al.
Published: (2015-01-01)

Erratum to “Profiling the anti-protozoal activity of anti-cancer HDAC inhibitors against Plasmodium and Trypanosoma parasites” [Int. J. Parasitol. Drugs Drug Res. 5 (2015) 117–126]
by: Jessica A. Engel, et al.
Published: (2016-12-01)

Drug Resistance in Visceral Leishmaniasis
by: Helena C. Maltezou
Published: (2010-01-01)

Clarification on a Published Paper in Iran J Parasitol
by: Serpil DEGERLI, et al.
Published: (2015-12-01)

Corrigendum to “Exposure of vaccinated and naive cattle to natural challenge from buffalo-derived Theileria parva” [Int. J. Parasitol. Parasites Wildl. 4(2) (2015) 244–251]
by: Tatjana Sitt, et al.
Published: (2017-12-01)

The Effect of Ursolic Acid on Leishmania (Leishmania) amazonensis Is Related to Programed Cell Death and Presents Therapeutic Potential in Experimental Cutaneous Leishmaniasis.
by: Eduardo S Yamamoto, et al.
Published: (2015-01-01)

Related Pentacyclic Triterpenes Have Immunomodulatory Activity in Chronic Experimental Visceral Leishmaniasis
by: Jéssica Adriana de Jesus, et al.
Published: (2021-01-01)

Repurposing Butenafine as An Oral Nanomedicine for Visceral Leishmaniasis
by: Adriana Bezerra-Souza, et al.
Published: (2019-07-01)

Elevated TGF-beta levels in drug-resistant visceral leishmaniasis
by: Miskelyemen A. Elmekki, et al.
Published: (2016-01-01)

PLGA-based macrophage-mediated drug targeting for the treatment of visceral leishmaniasis
by: Swati Gupta, et al.
Published: (2017-05-01)

The anti-tubercular drug delamanid as a potential oral treatment for visceral leishmaniasis
by: Stephen Patterson, et al.
Published: (2016-05-01)

Interstitial pneumonitis in canine visceral leishmaniasis
by: M. I. S. Duarte, et al.
Published: (1986-12-01)

A chronic bioluminescent model of experimental visceral leishmaniasis for accelerating drug discovery.
by: Raquel Álvarez-Velilla, et al.
Published: (2019-02-01)

Treatment of visceral leishmaniasis
by: E M Moore, et al.
Published: (2010-01-01)

Biochemical and nutritional evaluation of patients with visceral leishmaniasis before and after treatment with leishmanicidal drugs
by: Mariana Gatto, et al.
Published: (2013-12-01)

Amine modified graphene mediated drug delivery of Amphotericin B for the treatment of visceral leishmaniasis
by: S.L. Mudavath, et al.
Published: (2014-04-01)

Molecular characterization of Leishmania infantum strains and evaluation of new drugs to cure visceral leishmaniasis
by: Aluru, Srikanth
Published: (2014)

Drug susceptibility in Leishmania isolates following miltefosine treatment in cases of visceral leishmaniasis and post kala-azar dermal leishmaniasis.
by: Vasundhra Bhandari, et al.
Published: (2012-01-01)

Epidemiology and spatiotemporal analysis of visceral leishmaniasis in Palestine from 1990 to 2017
by: Amro Ahmad
Published: (2020-01-01)

Corrigendum: Leishmanicidal activities of Artemisia annua leaf essential oil against Visceral Leishmaniasis
by: Mohammad eIslamuddin, et al.
Published: (2015-09-01)

A poor-quality generic drug for the treatment of visceral leishmaniasis: a case report and appeal.
by: Thomas P C Dorlo, et al.
Published: (2012-01-01)

THYROID FUNCTION IN DOGS WITH VISCERAL LEISHMANIASIS
by: Mauro Jose Lahm Cardoso, et al.
Published: (2016-04-01)

Leishmaniasis visceral canina
by: Bruno L. Trav
Published: (2000-01-01)

Epidemiology of visceral leishmaniasis
by: Ready PD
Published: (2014-05-01)

Immunity to Visceral Leishmaniasis
by: Nahid Ali, et al.
Published: (2012-01-01)

Visceral leishmaniasis in children
by: mandana Rafeey, et al.
Published: (2005-02-01)

Immunobiology of visceral leishmaniasis
by: Susanne eNylén, et al.
Published: (2012-08-01)

Congenital Visceral Leishmaniasis
by: Catharina C. Boehme, et al.
Published: (2006-02-01)

Drug resistance in leishmaniasis
by: Jaya Chakravarty, et al.
Published: (2010-01-01)

Case Report: No Response to Liposomal Daunorubicin in a Patient with Drug-Resistant HIV-Associated Visceral Leishmaniasis.
by: Nicholas J Gow, et al.
Published: (2015-01-01)

Visceral leishmaniasis diagnosed by duodenal biopsy Leishmaniasis visceral diagnosticada por biopsia duodenal
by: L. del Olmo Martínez, et al.
Published: (2009-06-01)

Ursolic acid increases drug sensitivity of gemcitabine-resistant human pancreatic cancer cell
by: Zih-Ying Li, et al.
Published: (2019)

Chemoinformatics Strategies for Leishmaniasis Drug Discovery
by: Leonardo L. G. Ferreira, et al.
Published: (2018-11-01)

Imuno regulation in american visceral Leishmaniasis
by: E. M. Carvalho, et al.
Published: (1988-11-01)